Rapamycin Plays an Anti-Epileptic Role by Restoring Blood-Brain Barrier Dysfunction, Balancing T Cell Subsets and...

Area of Science:

• Neuroscience
• Pharmacology
• Immunology

Background:

• Rapamycin (RAP), a Mammalian Target of Rapamycin (mTOR) inhibitor, exhibits potential antiepileptic properties.
• Seizures involve the blood-brain barrier (BBB), neuroinflammation, lymphocytes, and neuronal apoptosis.

Purpose of the Study:

• To investigate if RAP's antiepileptic mechanism involves the BBB, neuroinflammation, lymphocytes, and neuronal apoptosis.

Main Methods:

• An epilepsy model was induced in rats using lithium chloride and pilocarpine.
• Epileptic rats were treated with varying doses of RAP (1, 2, 4 mg/kg/day).
• BBB proteins, inflammatory cytokines, T cell subsets, and cell apoptosis were analyzed.

Main Results:

• RAP reduced levels of BBB proteins (MMP-9, MMP-2, TIMP-1, TIMP-2) and inflammatory cytokines (IL-2, IFN-γ, TNF-α).
• RAP modulated T cell subsets, increasing total and T helper cells while decreasing cytotoxic T lymphocytes.
• RAP inhibited neuronal and glial cell apoptosis in the temporal lobe.

Conclusions:

• RAP's antiepileptic mechanism may involve restoring BBB function and reducing inflammation.
• Balancing T cell subsets and inhibiting apoptosis in the temporal lobe are potential mechanisms of RAP's action.